CLDND1 antibody
Principal name
CLDND1 antibody
Alternative names for CLDND1 antibody
GENX-3745, C3orf4, HSPC174, PSEC0054, UNQ2511, PRO6000, Claudin domain-containing protein 1
Ncbi ID
NP_001035271, NM_019895, NM_001040181, NM_001040183, NM_001040199, NM_001040200, NP_063948, NP_001035271.1, NM_171826, NM_001040182
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of CLDND1 antibody
- Kit Component:
- - KN201014G1, CLDND1 gRNA vector 1 in pCas-Guide vector
- KN201014G2, CLDND1 gRNA vector 2 in pCas-Guide vector
- KN201014D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Liu,Y., (2007) Lung Cancer 56 (3), 307-317
Human Muscle; WB Suggested Anti-CLDND1 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human Muscle; CLDND1 antibody - middle region (ARP44926_P050) in Human Muscle cells using Western Blot
Western blot analysis of CLDND1 Antibody (Center) (Cat. #AP50953PU-N) in mouse cerebellum tissue lysates (35µg/lane). CLDND1 (arrow) was detected using the purified Pab.
WB Suggested Anti-CLDND1 Antibody Titration: 0.2-1 ug/ml; Positive Control: Human Muscle
Gel: 12%SDS-PAGE, Lysate: 40 ug, Lane 1-2: Hepg2 cells, K562 cells, Primary antibody: (CLDND1 Antibody) at dilution 1/500, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 3 minutes
The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using (CLDND1 Antibody) at dilution 1/50, on the right is treated with fusion protein. (Original magnification: ×200)
The image on the left is immunohistochemistry of paraffin-embedded Human brain tissue using (CLDND1 Antibody) at dilution 1/50, on the right is treated with fusion protein. (Original magnification: ×200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA335968 | CLDND1 antibody |
||||||
| Rabbit Polyclonal Anti-CLDND1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, Hu, Ms, Por, Rb, Rt | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA349283 | CLDND1 antibody |
||||||
| Rabbit Polyclonal Anti-CLDND1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +2 additional images |
|||||||
| AP50953PU-N | CLDND1 (Center) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu, Ms | WB |
0.4 ml /
€370.00
|
|
| Acris Antibodies GmbH | |||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN201014 | CLDND1 - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN201014BN | CLDND1 - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN201014LP | CLDND1 - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN201014RB | CLDND1 - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP301014 | CLDND1 (transcript variant 2) |
||||
| Recombinant protein of human claudin domain containing 1 (CLDND1), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY412679 | CLDND1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY421715 | CLDND1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY421717 | CLDND1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY421724 | CLDND1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY421725 | CLDND1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY425697 | CLDND1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY425699 | CLDND1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY425703 | CLDND1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC205502L2V | Lenti ORF particles, CLDND1 (mGFP-tagged) - Human claudin domain containing 1 (CLDND1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC201014L2V | Lenti ORF particles, CLDND1 (mGFP-tagged) - Human claudin domain containing 1 (CLDND1), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC211544L2V | Lenti ORF particles, CLDND1 (mGFP-tagged) - Human claudin domain containing 1 (CLDND1), transcript variant 3, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC223606L2V | Lenti ORF particles, CLDND1 (mGFP-tagged) - Human claudin domain containing 1 (CLDND1), transcript variant 4, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€989.00
|
|
| OriGene Technologies, Inc. | ||
